Ellen Schlette

3.4k total citations
69 papers, 2.3k citations indexed

About

Ellen Schlette is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Ellen Schlette has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 44 papers in Pathology and Forensic Medicine and 19 papers in Immunology. Recurrent topics in Ellen Schlette's work include Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (43 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Ellen Schlette is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (43 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Ellen Schlette collaborates with scholars based in United States, Greece and Australia. Ellen Schlette's co-authors include L. Jeffrey Medeiros, Michael J. Keating, Raymond Lai, George Z. Rassidakis, William G. Wierda, Susan O’Brien, Alessandra Ferrajoli, Francisco Vega, Lynne V. Abruzzo and Mihaela Onciu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Ellen Schlette

67 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Schlette United States 28 1.3k 1.3k 701 700 632 69 2.3k
Thomas E. Boyd United States 22 1.4k 1.1× 1.2k 0.9× 751 1.1× 727 1.0× 555 0.9× 56 2.4k
Stephen E. Spurgeon United States 25 1.6k 1.2× 1.3k 1.0× 794 1.1× 690 1.0× 549 0.9× 98 2.4k
Mats Merup Sweden 24 1.1k 0.8× 969 0.7× 739 1.1× 632 0.9× 658 1.0× 59 2.2k
Enrico Tiacci Italy 27 1.1k 0.8× 1.1k 0.8× 1.1k 1.6× 703 1.0× 746 1.2× 77 2.8k
Sarah E. M. Herman United States 19 2.1k 1.6× 1.6k 1.2× 514 0.7× 504 0.7× 1.0k 1.6× 42 2.5k
Krimo Bouabdallah France 22 798 0.6× 1.4k 1.1× 293 0.4× 1.1k 1.6× 452 0.7× 119 2.1k
Katja Zirlik Germany 25 894 0.7× 707 0.5× 1.1k 1.6× 581 0.8× 814 1.3× 45 2.4k
Paul M. Barr United States 32 2.5k 1.9× 2.6k 2.0× 642 0.9× 1.2k 1.7× 951 1.5× 188 3.9k
Cheson Bd United States 10 1.5k 1.1× 1.3k 1.0× 273 0.4× 426 0.6× 788 1.2× 59 2.0k
Antonella Zucchetto Italy 23 1.2k 0.9× 862 0.7× 492 0.7× 307 0.4× 753 1.2× 79 1.8k

Countries citing papers authored by Ellen Schlette

Since Specialization
Citations

This map shows the geographic impact of Ellen Schlette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Schlette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Schlette more than expected).

Fields of papers citing papers by Ellen Schlette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Schlette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Schlette. The network helps show where Ellen Schlette may publish in the future.

Co-authorship network of co-authors of Ellen Schlette

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Schlette. A scholar is included among the top collaborators of Ellen Schlette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Schlette. Ellen Schlette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Huifei, Sa A. Wang, Ellen Schlette, et al.. (2018). Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Annals of Hematology. 97(10). 1775–1783. 9 indexed citations
2.
Garcés, Sofía, Joseph D. Khoury, Rashmi Kanagal‐Shamanna, et al.. (2018). Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption. Human Pathology. 82. 215–231. 11 indexed citations
3.
Boddu, Prajwal, Ellen Schlette, Beenu Thakral, et al.. (2017). Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report. Hematology/Oncology and Stem Cell Therapy. 12(3). 161–165. 2 indexed citations
4.
5.
Muñoz, Javier, Ellen Schlette, & Razelle Kurzrock. (2013). Rapid Response to Vemurafenib in a Heavily Pretreated Patient With Hairy Cell Leukemia and a BRAF Mutation. Journal of Clinical Oncology. 31(20). e351–e352. 53 indexed citations
6.
Leventaki, Vasiliki, Ηλίας Δράκος, Pei Lin, et al.. (2013). c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma. Human Pathology. 45(3). 565–572. 24 indexed citations
7.
Δράκος, Ηλίας, Vasiliki Leventaki, Vassilios Atsaves, et al.. (2011). Expression of serine 194–phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non–Hodgkin lymphomas. Human Pathology. 42(8). 1117–1124. 12 indexed citations
8.
Singh, Rajesh R., Kranthi Kunkalla, Chuanxing Qu, et al.. (2011). ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene. 30(49). 4874–4886. 139 indexed citations
9.
Δράκος, Ηλίας, George Z. Rassidakis, Ellen Schlette, et al.. (2011). Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21). Leukemia. 25(5). 856–867. 54 indexed citations
10.
Admirand, Joan H., Kevin R. Coombes, Constantine S. Tam, et al.. (2010). Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression. Modern Pathology. 23(11). 1518–1523. 17 indexed citations
11.
Δράκος, Ηλίας, et al.. (2009). The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53. Leukemia. 23(12). 2290–2299. 37 indexed citations
12.
Ferrajoli, Alessandra, Bang-Ning Lee, Ellen Schlette, et al.. (2008). Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood. 111(11). 5291–5297. 304 indexed citations
13.
Δράκος, Ηλίας, Vasiliki Leventaki, Ellen Schlette, et al.. (2007). c-Jun Expression and Activation are Restricted to CD30+ Lymphoproliferative Disorders. The American Journal of Surgical Pathology. 31(3). 447–453. 33 indexed citations
14.
Cotta, Claudiu, Vasiliki Leventaki, Vassilios Atsaves, et al.. (2007). The helix‐loop‐helix protein Id2 is expressed differentially and induced by myc in T‐cell lymphomas. Cancer. 112(3). 552–561. 18 indexed citations
15.
Onciu, Mihaela, Ellen Schlette, Yinmei Zhou, et al.. (2006). Secondary chromosomal abnormalities predict outcome in pediatric and adult high‐stage Burkitt lymphoma. Cancer. 107(5). 1084–1092. 37 indexed citations
16.
Ren, Yin, Nalân Akyürek, Ellen Schlette, Georgios Z. Rassidakis, & L. Jeffrey Medeiros. (2006). Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas. Human Pathology. 37(11). 1407–1413. 12 indexed citations
17.
Schlette, Ellen, George Z. Rassidakis, Özlem Canöz, & L. Jeffrey Medeiros. (2005). Expression of bcl-3 in Chronic Lymphocytic Leukemia Correlates With Trisomy 12 and Abnormalities of Chromosome 19. American Journal of Clinical Pathology. 123(3). 465–471. 5 indexed citations
18.
Merchant, Shakil H., Ellen Schlette, Warren G. Sanger, Raymond Lai, & L. Jeffrey Medeiros. (2003). Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.. Archives of Pathology & Laboratory Medicine. 127(3). 305–309. 16 indexed citations
19.
Hao, Suyang, Warren G. Sanger, Mihaela Onciu, et al.. (2002). Mantle Cell Lymphoma with 8q24 Chromosomal Abnormalities: a Report of 5 Cases with Blastoid Features. Modern Pathology. 15(12). 1266–1272. 84 indexed citations
20.
Schlette, Ellen, Carlos E. Bueso‐Ramos, Francis J. Giles, et al.. (2001). Mature B-Cell Leukemias With More Than 55% Prolymphocytes. American Journal of Clinical Pathology. 115(4). 571–581. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas E. Boyd Breakdown of academic impact, for papers by Stephen E. Spurgeon Breakdown of academic impact, for papers by Mats Merup Breakdown of academic impact, for papers by Enrico Tiacci Breakdown of academic impact, for papers by Sarah E. M. Herman Breakdown of academic impact, for papers by Krimo Bouabdallah Breakdown of academic impact, for papers by Katja Zirlik Breakdown of academic impact, for papers by Paul M. Barr Breakdown of academic impact, for papers by Cheson Bd Breakdown of academic impact, for papers by Antonella Zucchetto
Rankless by CCL
2026